AK0610 is engineered from an antibody isolated from a recovered infant and targets the pre-fusion F protein of RSV.

Knoxville, filed a bill Monday that would require Arkansas' Medicaid program to provide blood pressure monitors to pregnant ...

When you think of Carla Hall, delicious food, a friendly personality and distinctive eyewear may come to mind. But Hall, of Food Network, “The Chew” and “Top Chef” fame, is adding another role to her ...

Rumours that Donald Trump had chosen Martin Makary as FDA Commissioner have been confirmed, while the President-elect has ...

TUMBLING around on the floor with her big brother Oscar, happy three-year-old Aria Flynn is just like any other child her age ...

President-elect Donald Trump’s proposed lineup to lead the government’s health agencies look like bad news for vaccine ...

Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, according to two studies published online Nov. 25 in Pediatrics.

Researchers estimate that 123,000 to 193,000 U.S. adults were hospitalized each year with respiratory syncytial virus in ...

A new RSV treatment has been cleared by the CDC and FDA and doctors are calling it a gamechanger for children. News4’s ...

Amartya Mukhopadhyay's battery prototype is approximately 30 per cent cheaper than lithium-ion batteries, operates in a ...